Search clinical trials for: Icosapent Ethyl

Total 662 results

University of Louisville

Recruiting

Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP) (ARTCAP)

Coronary Artery Disease | Atherosclerosis | Heart Attack

United States
University of Leeds
National Cancer Institute (NCI); Massachusetts General Hospital; Massachusetts... and other collaborators

Recruiting

Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver Metastases

Colon Cancer Liver Metastasis

United Kingdom
Canadian Medical and Surgical Knowledge Translation...
Unity Health Toronto; Western University, Canada; HLS Therapeutics, Inc

Completed

The Use of Icosapent Ethyl on Vascular Progenitor Cells in Individuals With Elevated Cardiovascular Risk (IPE-PREVENTION)

Cardiovascular Diseases | Diabetes Mellitus, Type 2 | Cardiovascular Risk Factor | Triglycerides High

Canada
National Cancer Institute (NCI)

Terminated

Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body

Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Inflammatory Carcinoma

United States
VA Office of Research and Development
University of Wisconsin, Madison

Completed

Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid (BRAVE-EPA)

Alzheimer's Disease

United States
Mark A Hull, PhD FRCP
Yorkshire Cancer Research; Amarin Pharma Inc.

Active, not recruiting

EPA for Metastasis Trial 2 (EMT2)

Colon Cancer | Liver Metastasis

United Kingdom
Kaiser Permanente
Amarin Corporation

Terminated

A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults (MITIGATE)

Cardiovascular Diseases | Covid19 | Atherosclerosis | Upper Respiratory Tract Infections

United States
Mochida Pharmaceutical Company, Ltd.
Sumitomo Pharma (Suzhou) Co., Ltd.

Active, not recruiting

Efficacy of Ethyl Icosapentate in Patients With Severe Hypertriglyceridemia

Hypertriglyceridemia

China
Canadian Medical and Surgical Knowledge Translation...
HLS Therapeutics, Inc

Completed

Generalizability of REDUCE-IT Results to People of South Asian Descent With Atherosclerotic Cardiovascular Disease in Canada (REDUCE-IT Canada SA)

Myocardial Infarction | Cardiovascular Diseases | Coronary Heart Disease | Atherosclerotic Cardiovascular Disease

Canada
Lundquist Institute for Biomedical Innovation at...
Intermountain Research and Medical Foundation

Completed

Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy (EVAPORATE)

Hypertriglyceridemia

United States
New York State Psychiatric Institute

Withdrawn

A PET Study With [11C]PBR-28 and an Experimental Medication, Ethyl Eicosapentaenoic Acid

Bipolar Disorder

United States
Amarin Pharma Inc.

Completed

Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL (MARINE)

Hypertriglyceridemia

United States, Netherlands, Russian Federation, Ukraine, Denmark, Finland, Germany, India, Italy, Mexico, South Africa
Amarin Pharma Inc.

Completed

Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL) (ANCHOR)

Hypertriglyceridemia

United States
Amarin Pharma Inc.

Completed

A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin (REDUCE-IT)

Cardiovascular Diseases

United States, Australia, Canada, India, Netherlands, New Zealand, Poland, Romania, Russian Federation, South Africa, Ukraine
Brigham and Women's Hospital

Terminated

Effects of Eicosapentaenoic Acid on Endothelial Function in Diabetic Subjects

Coronary Artery Disease | Type 2 Diabetes

United States
Matinas BioPharma Nanotechnologies, Inc.
MB Clinical Research and Consulting LLC; Matinas Biopharma, Inc

Completed

Pharmacodynamic Effects of a Free-Fatty Acid Formulation of Omega-3 Pentaenoic Acid in Adults With Hypertriglyceridemia (ENHANCE-IT)

Hypertriglyceridemia

United States
Canadian Medical and Surgical Knowledge Translation...
HLS Therapeutics, Inc; Amarin Corporation

Completed

An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19

COVID-19 | Inflammatory Response

Canada
Massachusetts General Hospital
Harvard School of Public Health (HSPH)

Withdrawn

OMega-3 Fatty Acid for the Immune Modulation of Colorectal Cancer (OMICC)

Colon Cancer

United States
University of Pennsylvania
Amarin Pharma Inc.

Completed

Vascepa to Accelerate Lipoprotein Uptake and Elimination (VALUE)

Dyslipidemias | Lipid Disorder | Triglycerides High

United States
Estudios Clínicos Latino América
Amarin Pharma Inc.

Completed

PREPARE-IT. Prevention and Treatment of COVID19 With EPA in Subjects at Risk - Intervention Trial (PREPARE-IT)

COVID19

Argentina
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Terminated

Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced Cancer

Fatigue | Advanced Malignant Neoplasm

United States
Wihuri Research Institute
Karolinska Institutet; University of Helsinki; Minerva Foundation Institute for...

Unknown

The Effect of E-EPA on Circulating LDL and Plasma Lipid Metabolism (EPA&LDL)

Cardiovascular Diseases | Atherosclerosis | Low-density Lipoproteins Aggregation Susceptibility | Low-density Lipoprotein Lipid Composition

Finland
Mochida Pharmaceutical Company, Ltd.

Completed

Efficacy of MND-2119 in Participants With Hypertriglyceridemia

Hypertriglyceridemia

Japan
AstraZeneca

Completed

Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®) (ECLIPSEIII)

Hypertriglyceridemia

United States
Mochida Pharmaceutical Company, Ltd.

Completed

Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)

Steatohepatitis

United States, Puerto Rico
University Hospital, Aker
University of Oslo; AstraZeneca; Norwegian University of Science and Technology; Diakonhjemmet Hospital and other collaborators

Completed

Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants

Psychotic Disorders | Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorders

Norway
Ohio State University

Not yet recruiting

Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)

Preterm Birth | Pregnancy, High Risk | Preterm Premature Rupture of Membrane

United States
Chiesi Farmaceutici S.p.A.

Recruiting

Effect of Erythromycin on the Absorption, Metabolism and Elimination of CHF6001 in Healthy Volunteers

Chronic Obstructive Pulmonary Disease

Bulgaria
TC Erciyes University

Recruiting

Effect of Different Irrigation Solutions on Postoperative Pain and Lesion Healing

Endodontic Disease

Turkey
Maximilian Stahl, MD
Syndax Pharmaceuticals

Not yet recruiting

Revumenib in Combination With 7+3 + Midostaurin in AML

Acute Myeloid Leukemia | Leukemia | AML | AML, Adult | AML With Gene Mutations

United States
Taichung Veterans General Hospital

Not yet recruiting

The Effect of Platelet-rich Plasma Nasal Injection in the Treatment of Traumatic Olfactory Dysfunction (PRP)

Effect of Drug | Traumatic Olfactory Nerve Injury With Anosmia (Diagnosis)

Taiwan
Inova Fairfax Hospital

Recruiting

Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes (PRACET)

Premature Rupture of Membrane

United States
Washington State University
National Institute on Alcohol Abuse and Alcoholism (NIAAA); Weill Medical College... and other collaborators

Not yet recruiting

Virtual Incentive Treatment for Alcohol (VITA)

Alcohol Drinking | Alcohol Dependence | Alcohol Use Disorder | Alcohol Abuse

United States
OHSU Knight Cancer Institute
Genentech, Inc.; Oregon Health and Science University

Not yet recruiting

Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma

Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma

United States
Beijing Chest Hospital
West China Hospital; Wuhan Pulmonary Hospital (Wuhan Institute For Tuberculosis...

Recruiting

Clinical Study of JDB0131 Benzenesulfonate Tablets in Patients With Drug-sensitive Pulmonary Tuberculosis

Drug-resistant Tuberculosis

China
National Cancer Institute (NCI)

Not yet recruiting

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Breast Carcinoma | Breast Ductal Carcinoma In Situ | Breast Lobular Carcinoma In Situ | Breast Atypical Hyperplasia

United States
Owlstone Ltd

Recruiting

Diagnostic Accuracy Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution Phase 2)

Lung Cancer

United Kingdom, Czechia, Hungary
Hospices Civils de Lyon

Not yet recruiting

Role of BMP Pathway in MDS Progression (BMP-MDS)

Myelodysplastic Syndromes | Acute Myelogenous Leukemia

France
National Cancer Institute (NCI)

Recruiting

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Neuroblastoma | Ganglioneuroblastoma

United States
University of Washington
National Cancer Institute (NCI)

Recruiting

Supraphysiological Androgen to Enhance Chemotherapy Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study

Castration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma

United States
Mohammed Bin Rashid University of Medicine and...

Recruiting

Efficacy of Ethyl Chloride Topical Anesthesia Application on the Pain Perception During Intra-oral Injections in Children in Comparison to Benzocaine Gel.

Anesthesia, Local | Dental Caries in Children | Injection Site Discomfort

United Arab Emirates
Pharmazz, Inc.

Recruiting

A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients

Hypovolemic Shock

India
University of Rochester NCORP Research Base
National Cancer Institute (NCI)

Recruiting

High-Dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients

Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8

United States
David Bond, MD

Recruiting

Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma

Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Recurrent... and other conditions

United States
Assiut University

Not yet recruiting

Comparative Study of Polidocanol and Absolute Alcohol for Percutaneous us Guided Treatment of Benign Thyroid Cyst

Benign Thyroid Nodule | Thyroid Lump | Thyroid Cyst
National Cancer Institute (NCI)

Recruiting

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus Everolimus in Patients With Metastatic Unresectable Midgut Neuroendocrine Tumors, NET RETREAT Trial

Metastatic Midgut Neuroendocrine Tumor | Unresectable Midgut Neuroendocrine Tumor | Metastatic Midgut Neuroendocrine Tumor G1 | Metastatic Midgut Neuroendocrine Tumor G2

United States, Canada
National Cancer Institute (NCI)

Recruiting

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

United States, Puerto Rico, Canada
Thomas Jefferson University

Recruiting

Palbociclib or Tazemetostat in Combination With CPX-351 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia

United States
NRG Oncology
National Cancer Institute (NCI)

Recruiting

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-small Cell Lung Cancer

Stage III Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Locally Advanced Lung Non-Small Cell Carcinoma

United States
Joseph Tuscano
National Cancer Institute (NCI); ADC Therapeutics S.A.

Recruiting

Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma

High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Double-Expressor Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements

United States

Search clinical trials for: Icosapent Ethyl

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations